The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
22 Stocks Moving in Friday’s Pre-Market Session
Gainers
GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society of Medicine General Assembly.
Marker Therapeutics Secures $13.1M Grant To Support MultiTAA Cell Therapy Trial
Marker Therapeutics Inc (NASDAQ:MRKR) received notice of a Product Development Research award of approximately $13.1 million from Texas’s Cancer Prevention and…
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas
Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and
Marker Therapeutics Q2 EPS $(0.13) Up From $(0.14) YoY
Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.13) per share. This is a 7.14 percent increase over losses of $(0.14) per share from the same period last year.
Marker Therapeutics To Present At The Virtual Raymond James Human Health Innovation Conference Jun. 21
ker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Earnings Scheduled For May 12, 2021
Companies Reporting Before The Bell
• PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.